HIV-Infected Children in Central Africa Have Low Antibody Levels to Vaccines
Author Information
Author(s): Tejiokem Mathurin C., Gouandjika Ionela, Béniguel Lydie, Zanga Marie-Claire Endegue, Tene Gilbert, Gody Jean C., Njamkepo Elisabeth, Kfutwah Anfumbom, Penda Ida, Bilong Catherine, Rousset Dominique, Pouillot Régis, Tangy Frédéric, Baril Laurence
Primary Institution: Centre Pasteur du Cameroun
Hypothesis
Do HIV-infected children have lower persistence of antibodies to vaccines compared to HIV-exposed uninfected children?
Conclusion
HIV-infected children have significantly lower levels of antibodies to EPI vaccines compared to HIV-exposed uninfected children.
Supporting Evidence
- Only 20% of children had expected antibody levels against all tested vaccines.
- HIV-infected children had significantly lower antibody levels to measles compared to uninfected children.
- The study found a high risk of low antibody levels in HIV-infected children with severe immunodeficiency.
Takeaway
Kids with HIV don't keep their vaccine protection as well as kids without HIV, so they might need extra shots.
Methodology
A cross-sectional study was conducted on children aged 18 to 36 months born to HIV-infected mothers, testing blood samples for antibodies to various vaccines.
Potential Biases
Potential bias due to the exclusion of children with severe health issues and reliance on self-reported vaccination status.
Limitations
The study did not include children with severe clinical status or those recently breastfed, which may limit the generalizability of the findings.
Participant Demographics
Children aged 18 to 36 months, born to HIV-infected mothers, living in Central Africa.
Statistical Information
P-Value
p<0.0001
Confidence Interval
95% CI for GMCs reported
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website